Private Equity Firm to Purchase Johnson & Johnson Ortho-Clinical Business for $4.15B

Carlyle Group, a private equity firm, has agreed to purchase Johnson & Johnson’s ortho-clinical testing business for $4.15 billion, according to a Mass Device report.

Advertisement

The diagnostics business works with screening, monitoring and identifying diseases. Carlyle plans to expand the business into emerging and established markets.

More Articles on Devices:
Aurora Spine Earns Nearly $10M in Private Placement of Common Shares
Tegra Medical Names J. Mark King as CEO
Stan Janosz Joins Phillips Precision Medicraft as Director of Continuous Improvement

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.